Farmacon recently has been contracted by PTC therapeutics for their study: Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy in Latin America

Farmacon recently has been contracted by PTC Therapeutics to provide ancillary services for their study called: Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy in Latin America.

You can see the link at http://bit.ly/PTCDuchenneTrial

If you need more information on how to refer a patient, please contact us at info@farmasc.com